Vistagen Therapeutics, Inc. - VTGN
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 09, 2026 | Chief Financial Officer | A | A | 75,000.0 | 0.0 | 0.0 | 75,000.0 | View | |
| Apr 09, 2026 | President and CEO | A | A | 71,268.0 | 0.0 | 0.0 | 71,268.0 | View | |
| Apr 09, 2026 | President and CEO | A | A | 3,732.0 | 0.0 | 0.0 | 3,732.0 | View | |
| Apr 09, 2026 | Chief Operating Officer | A | A | 56,248.0 | 0.0 | 0.0 | 56,248.0 | View | |
| Apr 09, 2026 | Chief Operating Officer | A | A | 18,752.0 | 0.0 | 0.0 | 18,752.0 | View | |
| Apr 09, 2026 | Chief Corp Development Officer | A | A | 75,000.0 | 0.0 | 0.0 | 75,000.0 | View | |
| Apr 09, 2026 | Chief Legal Officer | A | A | 56,247.0 | 0.0 | 0.0 | 56,247.0 | View | |
| Apr 09, 2026 | Chief Legal Officer | A | A | 18,753.0 | 0.0 | 0.0 | 18,753.0 | View | |
| Jan 05, 2026 | Chief Operating Officer | A | A | 4,386.0 | 0.5626 | 2,467.56 | 15,249.0 | View | |
| Dec 04, 2025 | Chief Financial Officer | A | A | 150,000.0 | — | — | 150,000.0 | View | |
| Nov 04, 2025 | — | A | A | 35,200.0 | — | — | 35,200.0 | View |